Shares in the company, which specialises in developing innovative films and coatings, closed Monday trading for 2.2 cents. The stock entered a trading halt on Tuesday at the company's request, pending today's announcement.

That announcement was released this morning and has clearly stoked investor interest.

Earlier today, shares in the ASX microcap stock were swapping hands for 4.6 cents apiece, up an eye-watering 109.1%.

After some likely profit-taking, shares are trading for 3.7 cents at the time of writing, still up an impressive 68.2%.

Any guesses?

If you said Nanoveu Ltd (ASX: NVU), give yourself a virtual gold star.

Here's what's got investors excited.

ASX microcap stock lifts off on binding agreement

The Nanoveu share price is going ballistic after the company reported it has signed a binding heads of agreement (HOA) with Rahum Nanotech.

The HOA replaces the non-binding memorandum of understanding the ASX microcap stock signed with the South Korean company back in November for exclusive distribution rights for Nanoveu's EyeFly3D in South Korea.

EyeFly3D is a film and software combination that allows users to experience 3D on everyday mobile handheld devices and other digital displays without requiring glasses.

Nanoveu has granted Rahum Nanotech exclusive distribution rights in South Korea. The company reported that minimum orders totalling US$19.73 million (AU$29.64 million) by 31 December 2026 will be required to maintain that exclusivity.

Subject to Rahum Nanotech meeting those minimum purchase requirements, the companies could mutually agree to extend the exclusivity.

The ASX microcap stock said it has received an initial cash deposit of US$70,000 from an initial order of US$372,000, which includes app development reimbursement. The company will supply 28,000 EyeFly3D screens for Android and Apple iPhones from this initial order.

What did management say?

Commenting on the binding agreement sending the ASX microcap soaring today, Nanoveu CEO Alfred Chong said:

Following signing the non-binding MOU in November last year, Nanoveu and Rahum Nanotech have progressed significantly in software development and evaluation of the South Korean market potential for Nanoveu's EyeFly3D products…

The HOA includes targeted future minimum purchase orders for many more EyeFly3D screens, which will be suitable for a wide range of Android and Apple iPhones, with screens for tablets also being developed.

Lee Myeong Hoon, president of Rahum Nanotech, looks to have further stoked investor interest in the growth prospects of this ASX microcap stock.

"We've chosen the EyeFly3D technology for its unparalleled clarity and breathtaking immersive experience," Hoon said.

He added, "With the vast potential we foresee in South Korea and the promising opportunities we've uncovered, we stand firm in our confidence to not only meet but surpass our targets ahead."

The post Guess which ASX microcap stock just rocketed 109% on a new deal! appeared first on The Motley Fool Australia.

At the time of writing, shares in the nanotechnology company are swapping hands for 10 cents apiece, up 88.68%.

Nanoshield is a self-disinfecting film composed of PET foil with a special resin layer, containing an active copper component. The film has undergone scientific testing to guarantee its anti-viral and anti-bacterial properties. It has been proven to eliminate 99.99% of OC43, a viral strain affecting humans that is also a surrogate for COVID-19.

Nanoshield can be applied to a number of surfaces including mobile phone covers, tablets, cases, and other products.

What's driving the Nanovue share price?

Investors are driving the Nanovue share price to a new 6-month high on the back of a positive update.

According to its release, Nanovue has secured leading food and beverage solutions provider, Nestlé Professional as its latest customer.

The partnership will entail Nestlé Professional using customised Nanoshield screen protectors for its out of home coffee machines. In addition, specific Nanoshield products will be available for 'We Proudly Serve Starbucks' coffee machines in selected markets.

This follows Nestlé Professional's own evaluation program which scientifically tested Nanoshield products at its facility in Switzerland. The results are expected to be publicly released in a peer reviewed journal in due course.

While no fixed term contract was signed, the order for Nanoshield is expected to generate $50,000 of revenue for Nanovue.

What did management say?

Nanovue executive chair and CEO Alfred Chong commented:

We are fortunate to be working with Nestlé, such a great global partner, Nestlé who understands the importance of Nanoshield and its efficacy in protecting against viruses– particularly against the COVID-19 virus.

Together both organizations have a strong desire to develop solutions which enable better health and safety outcomes for consumers in the new environment in which we are all now living.

Nestlé Professional head of R&D Zenon Mandralis added:

We continue to explore a wide range of novel solutions such as ordering through apps, touchless machines, and screen protectors to support our customers.

The screen protections are a great solution because they can be easily used on current beverage machines and complement existing enhanced hygiene measures, we already have in place for our coffee solutions.

The Nanovue share price has been accelerating by around 43% year to date however the bulk of those gains have been delivered today. Nanoveu shares reached a 52-week high of 11 cents in May last year. Following today's gains, the company has a market capitalisation of around $15 million .

The post Nanovue (ASX:NVU) share price rockets 89% on new customer win appeared first on The Motley Fool Australia.

At one point, the nanotechnology company's shares reached an intraday high of 7.2 cents. However, some profit-taking has led its shares to retrace back to 5.7 cents, up 14%.

Established in 2018, Nanoveu is focused on developing a range of products for the mobile phone and digital displays market. The company's flagship product, Nanoshield, is an antiviral protection technology that can be applied to a number of surfaces. This includes mobile phone covers, mobile phone cases, tablets, and more.

What's pushing the Nanoveu share price higher?

The Nanoveu share price is on the move after providing an update that could potentially boost its sales.

According to its release, Nanoveu advised that it has entered into an exclusive distribution agreement with Vital Medikal for its Nanoshield products to be delivered to the Republic of Turkey.

Nanoveu stated that while there were no product sale guarantees, a US$575,000 annual purchase target has been set for Vital Medikal to hold exclusivity rights. The agreement, effective immediately, will run for a 12-month period with an option to extend further pending a sales performance review.

With over 25 years of experience in the medical field, Vital Medikal is an established medical equipment distributor in Turkey. The company supplies crucial devices such as respirators, cathodes and pre-filled syringes to Turkish hospitals, clinics, and medical facilities.

It is believed that the Nanoshield products will complement Vital Medikal's existing business-to-business customer base.

In addition to the first agreement, Nanoveu also signed a non-exclusive distribution deal with Asia Pro Lab for Hong Kong. The initial arrangement does not stipulate the minimum sales that are to be achieved. The non-material purchase agreement of Nanoshield will be valid for a term of 12 months and automatically renew thereafter.

Formed in 2009, Asia Pro Lab specialises in detailing and customisation of interior and exterior alterations on vehicles. The company primarily uses vinyl wrapping to suit customer needs. Adopting Nanoshield products with Asia Pro Lab enables antiviral and antibacterial protection properties within the customised works.

What did the head of Nanoveu say?

Nanoveu executive chair and CEO Alfred Chong commented:

We are continuing to see an expansion of our distribution network across the globe, which is reflective of the momentum Nanoveu has built. It is clear that there is immense desire for greater protection against bacteria and viruses and this demand is not just from first-world countries – it is from a global phenomenon.

The company will continue to target further distribution agreements in major markets, which permit greater avenues to generate sales revenue from Nanoshield products.

The Nanoveu share price has gained 42% from this time last year, but is down 18% for 2021.

The post Why the Nanoveu (ASX:NVU) share price is roaring 14% higher appeared first on The Motley Fool Australia.